{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:33:54Z","timestamp":1788381234575,"version":"build-2803163510"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-031605"],"award-info":[{"award-number":["INV-031605"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R015600\/1"],"award-info":[{"award-number":["MR\/R015600\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth, and Development Office","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Community Jameel"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Serotype 2 oral poliovirus vaccine (OPV2) can revert to regain wild-type neurovirulence and spread to cause emergences of vaccine-derived poliovirus (VDPV2). After its global withdrawal from routine immunization in 2016, outbreak response use has created a cycle of VDPV2 emergences that threaten eradication. We implemented a hierarchical model based on VP1 region genetic divergence, time, and location to attribute emergences to campaigns and identify risk factors. We found that a 10 percentage point increase in population immunity in children younger than 5 years at the campaign time and location corresponds to a 18.0% decrease (95% credible interval [CrI], 6.3%\u201328%) in per-campaign relative risk, and that campaign size is associated with emergence risk (relative risk scaling with population size to a power of 0.80; 95% CrI, .50\u20131.10). Our results imply how Sabin OPV2 can be used alongside the genetically stable but supply-limited novel OPV2 (listed for emergency use in November 2020) to minimize emergence risk.<\/jats:p>","DOI":"10.1093\/infdis\/jiad004","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T20:30:44Z","timestamp":1673382644000},"page":"80-88","source":"Crossref","is-referenced-by-count":16,"title":["The Origins and Risk Factors for Serotype-2 Vaccine-Derived Poliovirus Emergences in Africa During 2016\u20132019"],"prefix":"10.1093","volume":"228","author":[{"given":"Elizabeth J","family":"Gray","sequence":"first","affiliation":[{"name":"Department of Infectious Disease Epidemiology, Imperial College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura V","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, Imperial College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda S","family":"Bandyopadhyay","sequence":"additional","affiliation":[{"name":"Bill and Melinda Gates Foundation , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isobel M","family":"Blake","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, Imperial College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C","family":"Grassly","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, Imperial College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"2023062813221130700_jiad004-B1","author":"Global Polio Eradication Initiative"},{"key":"2023062813221130700_jiad004-B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.02.050","article-title":"Enabling accelerated vaccine roll-out for public health emergencies of international concern (PHEICs): novel oral polio vaccine type 2 (nopv2) experience","author":"Macklin","journal-title":"Vaccine"},{"key":"2023062813221130700_jiad004-B3","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jiq140","article-title":"Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population","volume":"203","author":"Wassilak","year":"2011","journal-title":"J Infect Dis"},{"key":"2023062813221130700_jiad004-B4","doi-asserted-by":"crossref","first-page":"e1005728","DOI":"10.1371\/journal.ppat.1005728","article-title":"Preventing vaccine-derived poliovirus emergence during the polio endgame","volume":"12","author":"Pons-Salort","year":"2016","journal-title":"PLoS Pathog"},{"key":"2023062813221130700_jiad004-B5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12916-017-0937-y","article-title":"The risk of type 2 oral polio vaccine use in post-cessation outbreak response","volume":"15","author":"McCarthy","year":"2017","journal-title":"BMC Med"},{"key":"2023062813221130700_jiad004-B6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a009924","article-title":"Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative","volume":"150","author":"Fine","year":"1999","journal-title":"Am J Epidemiol"},{"key":"2023062813221130700_jiad004-B7","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1716677","article-title":"Type 2 poliovirus detection after global withdrawal of trivalent oral vaccine","volume":"379","author":"Blake","year":"2018","journal-title":"N Engl J Med"},{"key":"2023062813221130700_jiad004-B8","author":"World Health Organization."},{"key":"2023062813221130700_jiad004-B9","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3201\/eid1910.130028","article-title":"Emergence of vaccine-derived polioviruses, demo- cratic Republic of Congo, 2004\u20132011","volume":"19","author":"Gumede","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2023062813221130700_jiad004-B10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3201\/eid2203.151394","article-title":"Faster detection of poliomyelitis outbreaks to support polio eradication","volume":"22","author":"Blake","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2023062813221130700_jiad004-B11","author":"Global Polio Eradication Initiative"},{"key":"2023062813221130700_jiad004-B12","author":"World Health Organization"},{"key":"2023062813221130700_jiad004-B13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.aba1238","article-title":"Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine","volume":"368","author":"Macklin","year":"2020","journal-title":"Science"},{"key":"2023062813221130700_jiad004-B14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1473-3099(21)00453-9","article-title":"Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa","volume":"22","author":"Cooper","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2023062813221130700_jiad004-B15","author":"Global Polio Eradication Initiative"},{"key":"2023062813221130700_jiad004-B16","author":"WorldPop"},{"key":"2023062813221130700_jiad004-B17","doi-asserted-by":"crossref","first-page":"e31743","DOI":"10.1371\/journal.pone.0031743","article-title":"Population distribution, settlement patterns and accessibility across Africa in 2010","volume":"7","author":"Linard","year":"2012","journal-title":"PLoS One"},{"key":"2023062813221130700_jiad004-B18","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1128\/JVI.02354-07","article-title":"Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range","volume":"82","author":"Jorba","year":"2008","journal-title":"J Virol"},{"key":"2023062813221130700_jiad004-B19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/aje\/kwq320","article-title":"From emergence to eradication: the epidemiology of poliomyelitis deconstructed","volume":"172","author":"Nathanson","year":"2010","journal-title":"Am J Epidemiol"},{"key":"2023062813221130700_jiad004-B20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature10856","article-title":"A universal model for mobility and migration patterns","volume":"484","author":"Simini","year":"2012","journal-title":"Nature"},{"key":"2023062813221130700_jiad004-B21","author":"International Refugee Rights Initiative"},{"key":"2023062813221130700_jiad004-B22","doi-asserted-by":"crossref","first-page":"ofab264","DOI":"10.1093\/ofid\/ofab264","article-title":"Modeling poliovirus surveillance and immunization campaign quality monitoring costs for Pakistan and Afghanistan for 2019\u20132023","volume":"8","author":"Kalkowska","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2023062813221130700_jiad004-B23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3390\/v11090859","article-title":"Recombination in enteroviruses, a multi-step modular evolutionary process","volume":"11","author":"Muslin","year":"2019","journal-title":"Viruses"},{"key":"2023062813221130700_jiad004-B24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/rmv.660","article-title":"Recombination among picornaviruses","volume":"20","author":"Lukashev","year":"2010","journal-title":"Rev Med Virol"},{"key":"2023062813221130700_jiad004-B25","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/infdis\/jiu182","article-title":"Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and meta-analysis","volume":"210","author":"Parker","year":"2014","journal-title":"J Infect Dis"},{"key":"2023062813221130700_jiad004-B26","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries","volume":"13","author":"Patriarca","year":"1991","journal-title":"Rev Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiad004\/49041806\/jiad004.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/1\/80\/50730741\/jiad004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/1\/80\/50730741\/jiad004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T13:23:02Z","timestamp":1687958582000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/228\/1\/80\/6984902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,11]]},"published-print":{"date-parts":[[2023,6,28]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiad004","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2023,1,11]]}}}